Bellicum Pharmaceuticals, Inc.
METHODS FOR ENHANCING AND MAINTAINING CAR-T CELL EFFICACY
Last updated:
Abstract:
The technology relates generally to the field of immunology and relates in part to compositions and methods for activating T cells and other cells resulting in an immune response against a target antigen. The technology also relates to compositions and methods for enhancing and maintaining chimeric antigen receptor-expressing T cells, while reducing cytotoxic effects of CAR-T cell therapies
Status:
Application
Type:
Utility
Filling date:
7 Dec 2018
Issue date:
5 Nov 2020